about
Anticoagulation with warfarin in infants and children.Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?Protein binding predictions in infantsSafety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates.Ontogeny of plasma proteins, albumin and binding of diazepam, cyclosporine, and deltamethrin.
P2860
description
1989 nî lūn-bûn
@nan
1989 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Drug binding properties of neonatal albumin
@ast
Drug binding properties of neonatal albumin
@en
Drug binding properties of neonatal albumin
@nl
type
label
Drug binding properties of neonatal albumin
@ast
Drug binding properties of neonatal albumin
@en
Drug binding properties of neonatal albumin
@nl
prefLabel
Drug binding properties of neonatal albumin
@ast
Drug binding properties of neonatal albumin
@en
Drug binding properties of neonatal albumin
@nl
P2860
P1476
Drug binding properties of neonatal albumin
@en
P2093
P2860
P356
10.1111/J.1651-2227.1989.TB11089.X
P407
P577
1989-05-01T00:00:00Z